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Abstract: Problem statement: Several investigators have indicated that case definitions for Chronic 
Fatigue Syndrome (CFS) are characterized by vaguely worded criteria that lack operational definitions 
and guidelines. The most widely used CFS case definition is the Fukuda et al. criteria, which uses 
polythetic criteria (i.e., patients are only required to have four out of a possible eight symptoms). Yet 
two of these eight symptoms (post-exertional malaise and memory/concentration problems) are an 
essential feature of this illness and the Fukuda et al. criteria do not require that these symptoms be 
present  among  all  patients.  Significant  methodological  problems  could  occur  if  investigators  in 
different settings recruit samples with different percentages of these core symptoms. In contrast, the 
Canadian clinical case definition does require specific ME/CFS  symptoms  such as post-exertional 
malaise and memory/concentration problems. The provision of operationally explicit, objective criteria 
on specific key symptoms might reduce criterion variance as a source of unreliability. In addition, the 
use of structured interview schedules  will ensure that symptoms are assessed in a consistent  way 
across  settings.  Conclusion/Recommendations:  In  this  article,  we  specified  explicit  rules  for 
determining whether critical symptoms meet ME/CFS criteria using a revised Canadian case definition 
and a questionnaire has been developed to assess core symptoms. It is hoped that these developments 
will lead to increased reliability of this revised Canadian case definition as well as more frequent use 
of these criteria by investigators. 
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INTRODUCTION 
 
  Efforts  to  develop  a  CFS  case  definition  can  be 
traced  back  to  the  1950s.  In  1955,  there  was  an 
outbreak  of  a  CFS-like  illness  at  the  Royal  Free 
Hospital  and  Ramsay  (1981;  1988),  the  medical 
consultant  in  charge,  published  a  number  of 
descriptions  of  this  disease,  which  subsequently 
became  known  as Myalgic  Encephalomyelitis  (ME) 
(Hyde et al., 1992) (Ramsay used a different term in his 
early  research,  but  he  changed  after  Acheson  (1959) 
came  up  with  ME).  Based  on  Ramsay’s  concept, 
research criteria were developed by Dowsett et al. (1990) 
and  (1994)    and  recently revised  by  Goudsmit  et  al. 
(2009) in an effort to distinguish the ME criteria from 
that of CFS. These ME case  definitions recognize the 
following four cardinal features: (1) physical or mental 
fatigue  or  muscle  weakness  after  minimal 
exertion which  may  persist  long  after  exertion  ends; 
(2) circulatory impairment (e.g., feeling hot when it’s 
cold, postural hypotension); (3) one or more symptoms 
indicating  the  involvement  of  the  central  nervous 
system  such  as  impairment  of  memory  and 
concentration and disturbed sleep patterns and (4) the 
marked  fluctuation  of  symptoms.  Other  symptoms 
emphasized  included:  Pain  and  autonomic  and Am. J. Biochem. & Biotech., 6 (2): 120-135, 2010 
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immunological  abnormalities  and  physicians  were 
alerted  to  inappropriate  night  or  daytime 
sweating, gastro-intestinal  disturbances,  dizziness  or 
vertigo,  hyperacusis,  blurred  vision, sore 
throat, headaches  and  intolerance  to  alcohol.  When 
Jason et al. (2003) attempted to operationalize some of 
these  ME  criteria  by  selecting  individuals  with  post-
exertional  malaise,  memory  and  concentration 
impairment  and  fluctuation  of  symptoms  and  then 
compared  these  patients  to  those  meeting  the  current 
US  definition  of  CFS  (Fukuda  et  al., 1994),  the  ME 
criteria selected a more symptomatic group of patients.  
  In 1998, Holmes et al. (1988) constructed the first 
US working case definition of CFS. According to this 
case definition, individuals needed to report six or more 
months  of  persistent  or  relapsing,  debilitating  fatigue 
that does not resolve with bedrest to meet criteria. Also, 
participants were required to report at least 8 of 11 minor 
symptoms (fever or chills, sore throat, lymph node pain, 
muscle weakness, muscle pain, post-exertional malaise, 
headaches  of  a  new  or  different  type,  migratory 
arthralgia, neuropsychiatric complaints, sleep disturbance 
and a sudden onset of symptoms). Participants were also 
required to report at least a 50%  impairment  of  daily 
functioning, as compared to premorbid levels. As the 
Holmes et al. (1988) criteria were utilized in research 
and  practice,  it  became  evident  that  there  were 
numerous  inconsistencies  in  interpretation  and 
classification.  For  example,  Katon  et  al.  (1991)  found 
that patients with CFS were indistinguishable from those 
with  chronic  fatigue  not  meeting  the  (Holmes  et  al., 
1988)  CDC  criteria.  Another  major  concern  was  that 
the requirement of eight or more minor symptoms could 
inadvertently  select  for  individuals  with  psychiatric 
problems (Katon and Russo, 1992).  
  A  few  years  later,  another  set  of  more  broadly 
defined  CFS  criteria  were  developed  by  British 
researchers  (Sharpe  et  al.,  1991).  To  qualify  for  a 
diagnosis  of  CFS  using  the  British  CFS  criteria,  the 
following  features  needed  to  be  present:  (1)  fatigue 
must be the principal symptom; (2) the syndrome must 
be definite in onset and not lifelong; (3) the syndrome 
must be severe, disabling and have an effect on physical 
and  mental  (cognitive)  functioning;  (4)  the  syndrome 
must  have been present for  six  months or  more than 
50%  of  the  time  and  (5)  other  symptoms  may  be 
present,  particularly  myalgias,  mood  and  sleep 
disturbance. These criteria were not frequently used by 
investigators,  as  they  were  considered  considerably 
broader than the Holmes et al. (1988) criteria and a few 
years  later,  international  consensus  developed  a  new 
CFS case definition (Fukuda et al., 1994).  
  In  1994,  with  sponsorship  from  the  Centers  for 
Disease  Control  and  prevention  (CDC)  in  the  US,  a 
revised case definition for CFS (Fukuda et al., 1994) 
was developed and it is now used throughout the world. 
This  CFS  case  definition  requires  a  person  to 
experience  six  or  more  months  of  chronic  fatigue  of 
new or definite onset, that is not substantially alleviated 
by  rest,  not  the  result  of  ongoing  exertion  and  that 
results in substantial reductions in occupational, social 
and  personal  activities.  To  be  diagnosed  with  CFS, 
individuals also need to have the concurrent occurrence 
of four or more of eight symptoms that do not predate 
the fatigue and persists for six or more months since the 
onset (e.g., sore throat, lymph node pain, muscle pain, 
joint pain, post-exertional malaise, headaches of a new 
or different type, memory and concentration difficulties 
and unrefreshing sleep). Although the first CFS criteria 
published by Holmes et al. (1988) (as specified by the 
Schluederberg  et  al.  (1992)  revision),  excluded 
individuals  with  the  presence  of  anxiety  disorders, 
somatoform  disorders  and  nonpsychotic  or 
nonmelancholic  depression  prior  to  CFS  onset,  these 
conditions  were  no  longer  exclusionary  under  the 
Fukuda  et  al.  case  definition.  Jason  et  al.  (2001) 
compared the Fukuda et al. (1994) and Holmes et al. 
(1988) criteria and found that the Holmes et al. (1988) 
criteria  selected  a  group  of  patients  with  higher 
symptomatology and functional impairment.  
  Unfortunately,  the  current  US  case  definition  for 
CFS (Fukuda et al., 1994) is characterized by vaguely 
worded criteria that are lacking operational definitions 
and guidelines to assist health care professionals in their 
interpretation  and  application  of  the  diagnostic  tool 
(Jason et al., 1999a; Reeves et al., 2003). In order to 
provide  more  guidelines  and  specific  criteria  for  this 
case  definition,  the  CDC  developed  an  empiric  case 
definition  for  CFS  that  involves  assessment  of 
symptoms, disability and fatigue (Reeves et al., 2005). 
The  CDC  empiric  case  definition  assesses  disability 
using  the  Medical  Outcomes  Study  Short  Form-36 
Health Survey (SF-36) (Ware et al., 2000); symptoms 
using the Symptom Inventory (Wagner et al., 2005) and 
fatigue  using  the  Multidimensional  Fatigue  Inventory 
(Smets et al., 1995). However, using these new empiric 
criteria,  the  estimated  prevalence  rates  of  CFS  have 
increased to 2.54% (Reeves et al., 2007), rates that are 
about  ten    times  higher  than  prior  CDC  estimates 
(Reyes et al., 2003)  and   prevalence   estimates of 
other  investigators  (Jason  et  al.,  1999b)  using  the 
Fukuda et al. criteria. It is possible that the increase in 
CFS  prevalence  in  the  United  States  is  due  to  a 
broadening of the Fukuda et al. case definition in an 
attempt  to  operationalize  the  criteria.  Further,  the Am. J. Biochem. & Biotech., 6 (2): 120-135, 2010 
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empiric  case  definition  has  potential  for  inclusion  of 
cases with primary psychiatric conditions. In support of 
this thesis, Jason et al. (2009a) found that 38% of those 
with a diagnosis of a Major Depressive Disorder were 
misclassified  as  having  CFS  using  the  new  CDC 
empiric case definition. 
  The  Fukuda  et  al.  (1994)  case  definition  uses 
polythetic criteria, that is, a set of symptoms in which 
not all need to be present to make a diagnosis. The use 
of polythetic criteria derived by expert committees (as 
is  the  case  with  CFS)  may  not  be  methodologically 
sound  (Jason  and  Choi,  2008).  For  example,  use  of 
polythetic criteria may result in the comparison of two 
different groups of patients within the same diagnostic 
category  or  similar  groups  in  different  diagnostic 
categories.  Because  the  Fukuda  et  al.  (1994)  criteria 
only  require  four  symptoms  out  of  a  possible  eight, 
critical CFS symptoms such as post-exertional malaise 
and  memory  and  concentration  problems  are  not 
required  of  all  patients  and  this  might  further 
complicate  identification  of  comparable  samples.  In 
contrast, a CFS case definition developed in Australia 
by  Lloyd  et  al.  (1990)  stipulated  that  post-exertional 
malaise,  as  well  as  memory  and  concentration 
difficulties were central for a diagnosis (this definition 
has not been frequently used, as is true with the British 
criteria). As mentioned above, the earlier ME definition 
involves  two  primary  symptoms:  post-exertional 
malaise and impairment of memory and concentration 
(Dowsett et al., 1994).  
  A clinical case definition for ME/CFS that is called 
the Canadian criteria also specified the these two core 
symptoms  as  well  as  several  other  symptoms 
(Carruthers et al., 2003). (The acronym ME/CFS refers 
to  Myalgic  Encephalomyelitis  and  Chronic  Fatigue 
Syndrome, according to the Canadian Case Definition. 
The patient community has felt that the term chronic 
fatigue  syndrome  trivializes  the  seriousness  of  this 
illness,  as  the  illness  is  typified  by  many  severe 
symptoms in addition to fatigue and fatigue is generally 
regarded as a common symptom experienced by many 
otherwise healthy individuals in the general population. 
The  term  Myalgic  Encephalomyelitis  had  been  used 
prior to the use of the term chronic fatigue syndrome 
(Acheson, 1959). The Canadian clinical case definition 
specifies that post-exertional malaise must occur with a 
loss  of  physical  or  mental  stamina,  rapid  muscle  or 
cognitive fatigability, usually taking 24 hours or longer 
to recover. In addition, there need to be two or more 
neurological/cognitive  manifestations  (e.g.,  confusion, 
impairment of concentration and short term-memory). 
There also needs to be unrefreshing sleep or poor sleep 
quantity or rhythm disturbance, as well as a significant 
degree of arthralgia and/or myalgia (there are a small 
number of patients with no pain or sleep dysfunction 
and  a  diagnosis  can  only  be  given  when  these 
individuals  have  a  classical  case  with  an  infectious 
illness  onset).  Finally,  there  needs  to  be  at  least  one 
symptom  from  two  of  the  following  categories: 
autonomic  manifestations  (neurally  mediated 
hypotension,  light  headedness),  neuroendocrine 
manifestations (e.g., recurrent feelings of  feverishness 
and cold extremities) and immune manifestations (e.g., 
recurrent  sore  throats).  Jason  et  al.  (2004)  compared 
persons  meeting  the  Canadian  clinical  case  definition 
(Carruthers et al., 2003), the Fukuda et al. criteria and 
people  experiencing  chronic  fatigue  explained  by 
psychiatric reasons. The Canadian criteria, in contrast 
to  the  Fukuda  et  al.  criteria,  selected  cases  with  less 
psychiatric  comorbidity,  more  physical  functional 
impairment,  more  fatigue/weakness  and 
neuropsychiatric and  neurology  symptoms. Moreover, 
those  meeting  the  Canadian  criteria  were  more 
symptomatically  different  from  the  psychiatrically-
caused  chronic  fatigue  group  than  those  meeting  the 
Fukuda et al. (1994) criteria. 
  Jason  et  al.  (2006)  later  used  the  Canadian  case 
definition model to develop a pediatric case definition 
for ME/CFS. To meet criteria, youth needed to meet the 
following six classic categories including fatigue, post-
exertional malaise; unrefreshing sleep, or disturbance of 
sleep quantity or rhythm; myofascial pain, joint pain, 
abdominal  and/or  head  pain;  two  or  more 
neurological/cognitive  manifestations and at least one 
symptom  from  two  of  three  subcategories  including 
autonomic  manifestations,  neuroendocrine 
manifestations, or immune manifestations. In order to 
operationalize  these  symptoms,  a  questionnaire  was 
developed with specific questions relating to each of the 
categories  above.  Jason  et  al.  (2010a)  found  that  the 
Fukuda et al. (1994) criteria was less sensitive than the 
Pediatric  ME/CFS  criteria  in  identifying  pediatric 
ME/CFS  cases.  Jason  et  al.  (2010a)  developed  a 
separate  classification  for  those  who  met  almost  all 
criteria termed the Moderate ME/CFS clinical criteria. 
The  group  that  meets  full  criteria  might  be  most 
appropriately used for research criteria, whereas those 
with more moderate features are less impaired and more 
heterogeneous and thus, they might fall under a more 
clinical case definition.  
  More  restrictive  or  more  liberal  criteria  clearly 
have an effect on who is classified as having CFS but 
these  different  definitions  also  pose  difficulties  in 
interpreting results of related studies (Komaroff et al., 
1996). To deal with these problems, there have been 
efforts to use statistical methods to classify symptoms Am. J. Biochem. & Biotech., 6 (2): 120-135, 2010 
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of individuals with severe fatigue (Janal et al., 2006; 
Nisenbaum et al., 1998; 2004; Sullivan et al., 2005). 
For  example,  Friedberg  et  al.  (2000)  found  three 
symptom  factors  (cognitive  problems,  flu-like 
symptoms and neurological symptoms) in a sample of 
patients  with  CFS.  Also  using  factor  analysis  with 
patients diagnosed with CFS, Ray et al. (1992) found 
the  following  factors:  Emotional  distress,  fatigue, 
somatic symptoms and cognitive difficulty. Rowe and 
Rowe  (2002)  confirmatory  factor  analysis  with  a 
pediatric  sample  found  muscle  pain  and  fatigue, 
neurological/cognitive symptoms, abdominal, head and 
chest  pain  and  both  neurophysiological  and 
immunological factors.  
  Some of the theoretical benefits of using these types 
of statistical approaches to better understand symptoms 
can be demonstrated from a study by Jason et al. (2002a). 
They  used  factor  analysis  to  provide  support  for  the 
existence of four distinct components of chronic fatigue: 
Lack  of  Energy  (fatigue  intensity),  Physical  Exertion 
(fatigue  exacerbated  by  physical  exertion),  Cognitive 
Problems  (difficulties  with  short-term  memory, 
concentration  and  information  processing)  and  Fatigue 
and  Rest  (rest  or  sleep  is  not  restorative).  Two  of  the 
primary dimensions of fatigue that emerged in a sample 
meeting the Fukuda et al. (1994) criteria for CFS based 
on self-report (“CFS-like”) were post-exertional fatigue 
and cognitive problems. Using cluster analysis, Jason and 
Taylor (2002) found that a majority of individuals with 
CFS  with  moderate  to  severe  symptoms  could  be 
accurately classified into two clusters both with severe 
post-exertional  fatigue  but  different  levels  of 
improvement  after  rest.  This  study  also  found  more 
severe  cognitive  problems  in  the  clusters  of  patients 
having CFS. These finding support the designation of 
post-exertional fatigue and cognitive  problems  as  core 
symptoms, similar to what has been recommended in 
the ME criteria (Dowsett et al., 1994), the Australian 
case definition (Lloyd et al., 1990) and the Canadian 
clinical case definition for ME/CFS (Carruthers et al., 
2003).  
  Finally,  Jason  et  al.  (2007)  provided  individuals 
with  CFS  a  theoretically  driven  questionnaire  that 
featured  neuropsychiatric,  vascular,  inflammatory, 
muscle/joint,  infectious  and  other  symptoms.  When 
these  theoretically  derived  symptoms  were  factor 
analyzed,  a  more  interpretable  factor  structure  was 
identified than when factor analysis was applied to the 
eight  Fukuda  et  al.  (1994)  symptoms.  The  findings 
from  this  study  provide  empirical  support  for 
identifying the following six types of symptoms among 
those  with  CFS:  neurocognitive,  vascular, 
inflammation,  muscle/joint  pain,  infectious  and 
sleep/post-exertional  malaise.  Several  studies  have 
provided  empirical  support  for  examining  these 
different types of symptoms among patients with CFS 
including post-exertional malaise (Jason et al., 2002a; 
Jason  and  Taylor,  2002),  neuropsychological  or 
cognitive problems (Ray et al., 1992; Rowe and Rowe, 
2002;  Jason  et  al.,  2002a),  infectious  symptoms 
(Nisenbaum    et    al.,    1998;    Friedberg  et  al.,  2000; 
Rowe  and  Rowe,  2002),  muscle/joint  difficulties 
(Nisenbaum  et  al.,  2004;  Rowe  and  Rowe,  2002), 
vascular issues (Rowe and  Rowe, 2002; Jason et al., 
2002b), inflammatory problems (Corradi et al., 2006) 
and    unrefreshing      sleep    (Nisenbaum  et  al.,  2004; 
Jason et al., 2002a). It is interesting that the Canadian 
clinical case definition (Carruthers et al., 2003) requires 
all  six  areas  to  be  assessed,  whereas  vascular  and 
inflammatory    processes    are  not  assessed  by  the 
Fukuda et al. CFS criteria. These findings suggest that a 
broader  group  of  symptoms,  ones  which  are 
theoretically  derived,  might  be  needed  to  more 
accurately identify critical symptoms of those with this 
illness. 
  The  Canadian  case  definition  requires  specific 
ME/CFS  symptoms.  However,  the  provision  of 
operationally explicit, objective criteria is not enough to 
ensure  that  scientists  can  elicit  the  necessary 
information  to  permit  them  to  gather  reliable 
information. There is also a need to construct structured 
interview schedules that ensure that questions are asked 
in a consistent way and this increases the chance that 
data collected in different settings are comparable. This 
report specifies explicit rules for determining ME/CFS 
status using a revised Canadian case definition and a 
questionnaire to assess symptoms (for a copy, write the 
first author).  
 
The  revised  Canadian  ME/CFS  criteria:  The 
definition  presented  in  Table  1  has  elements  of  the 
Fukuda et al. (1994) case definition, along with some 
of the recommendations of Reeves et al. (2003). We 
have also incorporated the structure of the Canadian 
clinical  case  definition  for  ME/CFS  developed  by 
Carruthers  et  al.  (2003).  We  believe  that  requiring 
specific symptoms does capture the critical symptoms 
for a person with ME/CFS. However, we have tried to 
limit  the  types  of  symptoms  within  each  of  the 
Canadian  criteria  categories  to  allow  investigators  to 
more reliably categorize adult patients.   Am. J. Biochem. & Biotech., 6 (2): 120-135, 2010 
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Table 1: Criteria for the revised Canadian ME/CFS criteria 
Definition of Research ME/CFS criteria 
I.  Over the past 6 months, persistent or recurring chronic fatigue that is not lifelong and results in substantial reductions in previous levels of 
occupational, educational, social and personal activities. The concurrent occurrence of the following classic ME/CFS symptoms (See II 
through VI), which must have persisted or recurred during the past six months of illness (symptoms may predate the reported onset of 
fatigue). 
II.  Post-exertional malaise and/ or post-exertional fatigue. With activity (it need not be strenuous and may include walking up a flight of stairs, 
using a computer, or reading a book), there must be a loss of physical or mental stamina, rapid/sudden muscle or cognitive fatigability, post-
exertional malaise and/or fatigue and a tendency for other associated symptoms within the patient’s cluster of symptoms to worsen. The 
recovery is slow, often taking 2-24 hours or longer.  
III.  Unrefreshing sleep or disturbance of sleep quantity or rhythm disturbance. May include unrefreshing sleep, prolonged sleep (including 
frequent naps), disturbed sleep (e.g., inability to fall asleep or early awakening) and/or day/night reversal. 
IV.  Pain (or discomfort) that is often widespread and migratory in nature. At least one symptom from any of the following: 
 
Myofascial and/or joint pain.  Myofascial pain can include deep pain, abdomen/stomach pain, or achy and sore muscles. Pain, 
stiffness, or tenderness may occur in any joint but must be present in more than one joint and lacking edema or other signs of 
inflammation. 
 
Abdominal and/or head pain. May experience stomach pain or chest pain. Headaches often described as localized behind the eyes or in 
the back of the head. May include headaches localized elsewhere, including migraines. Headaches would need to be more frequent 
than they were before, which would indicate new pattern, of a new type as compared to headaches previously experienced (i.e., 
location  of  pain  has  changed,  nature  of  pain  has  changed),  or  different  in  severity  type  as  compared  to  headaches  previously 
experienced by the patient.   
V.  Two or more neurological/cognitive manifestations:  
 
·  Impaired memory (self-reported or observable disturbance in ability to recall information or events on a short-term basis) 
·  Difficulty focusing vision and attention (disturbed concentration may impair ability to remain on task, to screen out extraneous/excessive 
stimuli) 
Loss of depth perception 
·  Difficulty finding the right word  
·  Frequently forget what wanted to say 
·  Absent mindedness  
·  Slowness of thought 
·  Difficulty recalling information 
·  Need to focus on one thing at a time  
·  Trouble expressing thought 
·  Difficulty comprehending information 
·  Frequently lose train of thought 
·  Sensitivity to bright lights or noise 
·  Muscle weakness/muscle twitches 
VI.  At least one symptom from two of the following three categories:  
 
1.  Autonomic manifestations: Neurally mediated hypotension, postural orthostatic tachycardia, delayed postural hypotension, palpitations with 
or without cardiac arrhythmias, dizziness or fainting, feeling unsteady on the feet--disturbed balance, shortness of breath, nausea, bladder 
dysfunction, or irritable bowel syndrome. 
2.  Neuroendocrine manifestations Recurrent feelings of feverishness and cold extremities, subnormal body temperature and marked diurnal 
fluctuations, sweating episodes, intolerance of extremes of heat and cold, marked weight change-loss of appetite or abnormal appetite. 
3.  Immune manifestations: Recurrent flu-like symptoms, non-exudative sore or scratchy throat, repeated fevers and sweats, lymph nodes 
tender to palpitation--generally minimal swelling noted, new sensitivities to food, odors, or chemicals. 
 
VII.  Exclusionary versus Non-Exclusionary conditions: 
 
A.  Exclusionary conditions: 
 
1.  Any active medical condition that may explain the presence of chronic fatigue, such as: 
 
i.  Untreated hypothyroidism 
ii.  Sleep apnea 
iii.  Narcolepsy 
iv.  Malignancies 
v.  Leukemia 
vi.  Unresolved hepatitis  
vii.  Multiple Sclerosis  
viii.  Juvenile rheumatoid arthritis 
ix.  Lupus erythematosus 
x.  HIV/AIDS 
xi.  Severe obesity (BMI greater than 40; but if weight gain follows onset of ME/CFS, the patient could meet the Clinical Criteria) 
xii.  Celiac disease 
xiii.  Lyme disease  
 Am. J. Biochem. & Biotech., 6 (2): 120-135, 2010 
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Table 1: Continued 
2.  Some active psychiatric conditions that may explain the presence of chronic fatigue, such as: 
 
i.  Schizophrenia or psychotic disorders  
ii.  Bipolar disorder 
iii.  Active alcohol or substance abuse-except as below: 
a.  Alcohol or substance abuse that has been successfully treated and resolved should not be considered exclusionary. 
iv.  Active anorexia nervosa or bulimia nervosa-except as below: 
b.  Eating disorders that have been treated and resolved should not be considered exclusionary. 
v.  Depressive disorders with melancholic or psychotic features 
 
B.  Not necessarily exclusionary 
 
3.  May have presence of concomitant disorders that do not adequately explain fatigue and are, therefore, not necessarily exclusionary. 
 
i.  Psychiatric diagnoses such as: 
a.  Anxiety disorders 
b.  Somatoform disorders  
c.  Depressive disorders 
ii.  Other conditions defined primarily by symptoms that cannot be confirmed by diagnostic laboratory tests, such as: 
a.  Multiple food and/or chemical sensitivity 
b.  Fibromyalgia 
iii.  Any condition under specific treatment sufficient to alleviate all symptoms related to that condition and for  which the adequacy of 
treatment has been documented. 
iv.  Any condition that was treated with definitive therapy before development of chronic symptomatic sequelae. 
v.  Any isolated and unexplained physical examination, laboratory or imaging test abnormality that is insufficient to strongly suggest the 
existence of an exclusionary condition. 
 
  The  Canadian  ME/CFS  clinical  case  definition 
(Carruthers et al., 2003), states that “The patient must 
have  a  significant  degree  of  new  onset,  unexplained, 
persistent, or recurrent physical and mental fatigue that 
substantially  reduces  activity  level”  (p.6)  and  “the 
fatigue should be severe enough to substantially reduce 
the  patient’s  activity  level,  usually  by  approximately 
50%”  (p.14).  Finally,  the  authors  indicate  that  the 
illness usually has a distinct onset (although it may be 
gradual) and it persists for at least 6 months. 
 
The Fukuda et al. (1994) case definition states the 
following:  A case of the chronic fatigue syndrome is 
defined by the presence of the following:  (1) clinically 
evaluated, unexplained, persistent or relapsing chronic 
fatigue that is of new or definite onset (has not been 
lifelong); is not the result of ongoing exertion; is not 
substantially alleviated by rest and results in substantial 
reduction  in  previous  levels  of  occupational, 
educational,  social,  or  personal  activities  and  (2)  the 
concurrent occurrence of four or more of the following 
symptoms, all of which must have persisted or recurred 
during  6  or  more  consecutive  months  of  illness  and 
must not have predated the fatigue (p.956).  
  Given that some language used in the Fukuda et al. 
criteria  is  vague,  we  have  created  operational 
definitions to improve diagnostic reliability.  
  According to the Fukuda et al. (1994) criteria, a 6 
month period could have been over the last 6 months, 
or during a 6 month period a few years ago. We believe 
that the survey item should specify that these symptoms 
should be assessed over the last 6 months in order to 
determine  a  current  ME/CFS  diagnosis.  It  is  also 
unclear what is meant by “persisted or recurred.” This 
phrase  has  generally  referred  to  a  symptom  that  has 
been  ongoing  and  constant,  but  sometimes  there  are 
good periods and bad periods. We now operationalize 
this  phrase  by  assessing  how  often  the  person  has 
experienced the symptom (fatigue or other symptoms) 
over the past 6 months using the following scale:  0  = 
none  of  the  time,  1 = a little of the time, 2 = about 
half the time, 3 = most of the time, 4 = all of the time. 
To be counted as “persisted or recurred,” the individual 
would  have  to  indicate  a  score  of  2  or  higher.  In 
addition, it is important that fatigue and the other core 
symptoms  should  be  either  moderate  or  severe; 
however this “severity index” has not been well defined 
in  previous  criteria.  We  now  specify  that  existing 
symptoms be rated on the following scale: 0 = symptom 
not present, 1 = mild, 2 = moderate, 3= severe, 4 = very 
severe. Symptoms need to be rated at moderate (i.e., 2) 
or worse to meet criteria. Therefore, to meet criteria for 
a  given  symptom,  specific  frequency  and  severity 
ratings must be met over the past 6 months.  
  The threshold number of 4 out of 8 Fukuda et al. 
(1994) core symptoms has been changed and we now 
adopt a similar system to that used with the Canadian 
ME/CFS criteria (Carruthers et al., 2003). The DePaul 
Symptom Questionnaire provides a structured  way to 
gather standardized information that can be used to aid Am. J. Biochem. & Biotech., 6 (2): 120-135, 2010 
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in the diagnosis of ME/CFS. For meeting full criteria of 
ME/CFS, the following six classic ME/CFS symptom 
categories must occur. A scoring sheet for determining 
if a person meets ME/CFS criteria and how to score the 
SF-36 scales can also be obtained by writing the first 
author. 
 
Fatigue:  Our  first  criterion  involves  persistent  or 
recurring chronic fatigue over the past six months that 
is not lifelong and results in substantial reductions in 
previous levels of occupational, educational, social and 
personal  activities.  The  Fukuda  et  al.  (1994)  case 
definition requires that the fatigue not be lifelong and 
that it be of a new and definite onset. In a revision of 
the Fukuda et al. (1994) criteria, Reeves et al. (2003) 
stated that only participants who recount having always 
felt  severely  fatigued  should  be  excluded  as  having 
“lifelong” fatigue. We also decided to use this criterion 
in formulating the diagnostic criteria. A person would 
not meet this ME/CFS criterion if they answered yes to 
the  following  question:  “Have  you  always  had 
persistent  or  recurring  fatigue/energy  problems,  even 
back to your earliest memories as a child? By persisting 
or recurring, we mean that the fatigue/energy problems 
are usually ongoing and constant, but sometimes there 
are  good  periods  and  bad  periods.  The  original 
Canadian  criteria  mentioned  a  “distinct  onset”  but 
allowed for gradual onset. We agree with this guideline, 
but  also  note  that  onset  often  occurs  quickly  (within 
days/weeks),  especially  following  an  infectious 
epsiode/surgery/pregnancy.  This  is  not  always  when 
patients get all the symptoms but they notice a distinct 
difference in their health. 
  In terms of  fatigue severity  ratings, a  number of 
fatigue scales have been used, but Stouten (2005) has 
warned  that  many  fatigue  scales  do  not  accurately 
represent  the  severe  fatigue  that  is  characteristics  of 
ME/CFS.  Deciding  on  which  subscales  and  cut  off 
scores to use has also been problematic. For example, 
with  the  CDC  empiric  case  definition,  Reeves  et  al. 
(2005)  used  the  Multidimensional  Fatigue  Inventory 
(MFI) (Smets et al., 1995) to assess severe fatigue. The 
MFI scales range from 4-20 and Reeves et al. (2005) 
defined  severe  fatigue  as  a  score  of  greater  than  or 
equal to 13 on the MFI general fatigue scale or greater 
than or equal to 10 on the reduced activity scale. In one 
study of three groups with CFS, the mean MFI general 
fatigue scores were 18.3-18.8 (Tiersky et al., 2003) and 
these scores are clearly higher than the Reeves et al. 
(2005) cutoff of 13. In addition, reduced activity items 
refer  to  issues  that  a  person  with  depression  might 
easily endorse. If a person indicated that the following 
two items were entirely true: “I get little done,” and “I 
think  I  do  very  little  in  a  day,”  they  would  meet 
criterion  for  fatigue  on  this  scale.  Clearly,  almost  all 
individuals  with  depressive  disorders  would  meet  this 
reduced activity criterion. Jason et al. (2010b) also found 
that Reeves et al. (2005) cutoff scores for the MFI had 
inadequate sensitivity and specificity when attempting 
to differentiate ME/CFS cases from controls. 
  In  order  to  avoid  the  potential  pitfalls  associated 
with  previous  approaches  of  operationalizing  fatigue 
and  to  maintain  consistency  with  the  Fukuda  et  al. 
(1994) and Carruthers et al. (2003) case definitions, the 
ME/CFS fatigue criterion is met if a person indicates 
that  their  fatigue/extreme  tiredness  has  persisted  or 
recurred  over  the  past  6  months  at  frequency  and 
severity ratings of 2 or higher. A person must also meet 
the criteria for substantial reductions described below. 
Some patients with CFS are not chronically fatigued, 
but they have a problem of endurance or stamina and 
need  lengthy  times  to  recover  following  minimal 
degrees  of  activity  (Hyde,  1999).  A  person  with 
ME/CFS  who  participates  in  very  little  activity 
(possibly  to  minimize  ME/CFS  symptoms)  when 
compared to his or her same-age peers, could become 
exhausted upon minimal exertion. While normal fatigue 
is not activity limiting, the fatigue present in ME/CFS 
limits  the  individual’s  activity  to  varying  degrees. 
Therefore,  in  addition  to  assessing  whether  or  not  a 
person has persistent or recurring chronic fatigue over 
the  past  6  months,  we  have  added  questions  that 
identify  those  individuals  who  have  low  stamina  and 
endurance,  but  currently  have  less  fatigue/energy 
problems because they are severely limiting their daily 
activities.  Individuals  who  do  not  meet  the  fatigue 
criterion may still obtain a Clinical ME/CFS diagnosis 
if they meet the other five criteria.  
 
Substantial  reduction  in  functioning:  According  to 
the Fukuda et al. (1994) criteria, fatigue is associated 
with  substantial  reductions  in  “previous  levels  of 
occupational, educational, social, or personal activities” 
(p.956). Therefore, we have included an assessment of 
substantial  reductions  under  the  fatigue  criterion.  An 
instrument that has been frequently used to assess this 
disability  construct  is  the  Medical  Outcomes  Study 
Short  Form-36  Health  Survey  (SF-36)  (Ware  and 
Sherbourne, 1992). This instrument is a 36 item, broadly-
based, self report measure of functional status related to 
physical and social functioning, physical role functioning, 
emotional role functioning, bodily pain, general health, 
vitality, mental health and health transition. Higher scores 
on this scale indicate higher functioning. 
  Reeves et al. (2005) empiric CFS case definition 
selected four of the eight SF-36 subscales to measure Am. J. Biochem. & Biotech., 6 (2): 120-135, 2010 
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disability/substantial    reductions.      According    to 
Reeves  et  al.  (2005)  empiric  case  definition,  the 
disability criterion was met by scoring below the 25th 
percentile on at least one of the following four SF-36 
sub-scales: Physical Functioning (less than or equal to 
70),  Role-Physical  (less  than  or  equal  to  50),  Social 
Functioning  (less  than  or  equal  to  75),  or  Role-
Emotional (less than or equal to 66.7). Based on this 
system, a person could meet the disability CFS criteria 
without  any  reductions  in  key  areas  of  physical 
functioning  and  only  have  impairment  in  the  role 
emotional area (e.g., problems with work or other daily 
activities as a result of emotional problems). Jason et al. 
(2009a)  have  challenged  the  inclusion  of  the  Role-
Emotional subscale as not being appropriate because it 
assesses change in function as a result of any emotional 
problems. Ware et al. (2000) found that the mean for 
Role-Emotional  for  a  clinical  depression  group  was 
38.9,  indicating  that  almost  all  those  with  clinical 
depression would meet the CFS disability criterion, as 
they would be within the lower 25th percentile on this 
subscale.  
  Jason et al. (2010c) found that Role-Emotional had 
the  lowest  threshold  for  both  identifying  individuals 
with CFS and identifying others who did not have this 
illness.  However,  Vitality,  Social  Functioning  and 
Role-Physical have the highest threshold. In a literature 
review,  the  Vitality,  Social  Functioning  and  Role-
Physical subscales best discriminated those with CFS 
from controls (Jason et al., 2010c). The Vitality scale 
measures  items  that  assess  feeling  full  of  pep  and 
energy, as well as those that focus on feeling worn out 
or  tired.  Social  functioning  is  assessed  by  items  that 
involve interference with your normal social activities 
with  family,  friends,  neighbors  or  groups.  The  Role-
Physical subscale focuses on items assessing the need 
to  cut  down  or  limit  one’s  work,  social,  or  other 
activities, as well as accomplishing less than one might 
like.  In  other  words,  these  three  subscales  capture 
significant  limitations  in  the  person’s  ability  to  have 
energy and accomplish activities in life. To meet the 
substantial reduction criteria, we now stipulate that at a 
minimum, a person needs to meet criteria on two of the 
three designated subscales: Score less than or equal to 
35  for  Vitality,  less  than  or  equal  to  62.5  for  Social 
Functioning,  or  less  than  or  equal  to  50  for  Role-
Physical. The substantial reduction criteria must be met 
in  order  for  the  fatigue  criterion  of  the  Revised 
Canadian ME/CFS case definition to be met.  
 
Post-exertional  malaise  and/or  post-exertional 
fatigue:  With  activity  (it  need  not  be  strenuous  and 
may  include  walking  up  a  flight  of  stairs,  using  a 
computer,  reading  a  book  or  other  activities  of  daily 
living  such  as  dressing,  bathing,  eating,  cooking,  or 
shopping), there must be a loss of physical or mental 
stamina, rapid/sudden muscle or cognitive fatigability, 
post-exertional  malaise  and/or  post-exertional  fatigue 
and a tendency for other associated symptoms within 
the  patient’s  cluster  of  symptoms  to  worsen.  The 
recovery is slow, often taking 2-24 hours or longer.  
  Although a person with ME/CFS may feel better 
after rest, he or she may get sick again quickly upon 
minimal activity or exertion. In this case, the rest does 
not  completely  eliminate  the  syndrome  but  it  may 
provide  some  relief;  therefore,  this  symptom  pattern 
should not exclude a ME/CFS diagnosis. In the case of 
an  adult  who  is  active  (e.g.,  participates  in 
extracurricular  activities,  sports,  outings  with  friends) 
but exhausted, yet also recovers quickly when activity 
is decreased, the fatigue would be considered the result 
of  ongoing  exertion  or  activity  and  thus,  would  be 
excluded  from  a  diagnosis  of  ME/CFS.  However,  a 
person who participates in very little activity (possibly 
to minimize ME/CFS symptoms) when compared to his 
or her same-age peers and who also becomes exhausted 
upon minimal exertion, would meet the post-exertional 
malaise  criterion.  In  summary,  normal  fatigue  is  not 
activity limiting, whereas the fatigue/energy problems 
present  in  ME/CFS  limits  the  individual’s  activity  to 
varying degrees. A person experiences post-exertional 
malaise  when  recovery  does  not  occur  quickly  after 
exhausting  activity  or  when  activities  have  to  be 
restricted  to  avoid  experiencing  fatigue/energy 
problems, or when increased fatigue and/or worsening 
of symptoms are experienced after exercise.  
  Within a group of individuals diagnosed with CFS, 
Jason et al. (1999a) found that post-exertional fatigue 
or malaise for individuals with CFS ranged from 93.8-
40.6% depending on how the question was asked. There 
is certainly a need to standardize the questions used to 
reduce this source of unreliability. In addition, length of 
the  period  of  post-exertional  malaise  may  vary  from 
activity to activity or by time period within the person. 
It  would be  more  useful to  subgroup patients into the 
following groups rather than to discount the complaints 
of patients who do not report experiencing this symptom 
for 24 hours or longer: Post-exertional malaise lasting for 
1-6 hours; post-exertional malaise lasting for 7-23 hours; 
post-exertional  malaise  lasting  for  24  hours  or  longer, 
with exact length specified by patient.  
  Recently,  Jason  et  al.  (2009b)  developed  the 
ME/CFS  Fatigue  Types  Questionnaire  (MFTQ),  a  22 
item scale designed to  measure the duration, severity 
and  frequency  of  different  fatigue-related  sensations 
and symptoms. The MFTQ appears to be a reliable and Am. J. Biochem. & Biotech., 6 (2): 120-135, 2010 
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valid  measure  of  fatigue  types  in  individuals  with 
ME/CFS. When factor analyzed, several fatigue factors 
emerged  for  individuals  with  CFS  (Post-Exertional, 
Wired, Brain Fog, Energy and Flu-Like fatigue) but the 
healthy  control  group  only  experienced  one  overall 
factor  involving  generalized  fatigue.  Jason  et  al. 
(2010d)  found  that  the  post-exertional  factor  had 
adequate  sensitivity  and  specificity  (it  was  able  to 
identify individuals who had ME/CFS and also exclude 
individuals who did not have this illness). Five items 
from the MFTQ with the highest loadings on the post-
exertional  factor  included:  Dead,  heavy  feeling  that 
occurs  quickly  after  starting  to  exercise;  next  day 
soreness  or  fatigue  after  non-strenuous,  everyday 
activities;  mentally  tired  after  the  slightest  effort; 
physically  drained  or  sick  after  mild  activity  and 
minimum    exercise    makes    you    physically  tired 
(Jason et al. 2009b). We included these five items on 
the  DePaul  Symptom  Questionnaire  to  measure  post-
exertional malaise. To meet criteria for post-exertional 
malaise or post-exertional  fatigue, one of these items 
need to be endorsed at sufficient frequency and severity 
(2 or greater on a scale of 0-4). This number of items 
was  confirmed  as  having  the  best  sensitivity  and 
specificity (Jason et al., 2010d). 
 
Sleep:  The  third  symptom  category  is  unrefreshing 
sleep, or disturbance of sleep quantity or rhythm.  As 
discussed  above,  many  of  the  symptom  criteria  lack 
clear  guidelines  for  clinicians  to  follow  when 
conducting  an  assessment.  For  example,  there  are  no 
guidelines for how the term “unrefreshing sleep” should 
be  defined  and  evaluated.  Research  findings  indicate 
that tiredness is associated with any disturbance in sleep 
such as too much sleep, sleep at the wrong time and 
fragmented sleep. Patients  with  ME/CFS often report 
unrefreshing, disturbed, or poor quality sleep; however, 
the  Fukuda  et  al.  (1994)  case  definition  does  not 
adequately define “nonrestorative sleep” or specify how 
this complaint should be assessed. It is unclear whether 
this  symptom  would  be  counted  for  individuals  who 
report nonrestorative sleep for most but not all nights. 
Additionally,  it  is  not  specifically  stated  if  someone 
would  meet this criterion if  he or she has restorative 
sleep  but  other  sleep  problems  such  as  difficulties 
falling asleep, maintaining sleep, or waking up early. 
Komaroff et al. (1996) found that 98% of a chronically 
fatigued  group  had  sleep  disturbances,  but  only  89% 
reported  awakening  unrefreshed.  To  assess  sleep 
difficulties, it is important to assess for dysfunction in 
areas  beyond  just  nonrestorative  sleep  and  include 
prolonged  sleep  (including  frequent  naps),  disturbed 
sleep (e.g., inability to fall asleep or early awakening) 
and/or day/night reversal. We have included items in 
the DePaul Symptom Questionnaire that assess several 
symptom  indicators  of  sleep  dysfunction  and  one 
symptom  needs  to  meet  the  frequency  and  severity 
ratings of 2 or higher to meet the sleep criterion. 
 
Myofascial pain, joint pain, abdominal and/or head 
pain:  The  fourth  symptom  category  requires  that  the 
person exhibit  myofascial pain, joint pain, abdominal 
and/or  head  pain.  Myofascial  pain  can  include  deep 
pain, abdomen/stomach pain, or achy and sore muscles. 
Pain, stiffness, or tenderness may occur in any joint but 
must  be  present  in  more  than  one  joint  and  lacking 
edema  or  other  signs  of  inflammation.  The  pain 
criterion  is  met  if  a  person  meets  the  frequency  and 
severity ratings of 2 or higher for one pain symptom. 
  Pain is among the most frequently cited reasons for 
seeking medical attention. However, the assessment of 
pain is particularly difficult given that the experience of 
this complaint is highly subjective. For example, pain is 
difficult to describe and different descriptions may be 
used by two different individuals to describe the same 
phenomenon (Turk and Melzack, 1992). Furthermore, 
the  association  between  physical  abnormalities  and 
patients report of pain is often ambiguous and weakly 
correlated. Physical pathology also has not been found 
to be predictive of disability (Cats-Baril and Frymoyer, 
1991).  In  fact,  there  are  no  isomorphic  relationships 
between reports of pain, disability and tissue pathology. 
Given the inherent subjectivity of pain and the frequent 
absence  of  objective  findings  to  account  for  this 
symptom,  pain  can  only  be  assessed  indirectly  (Turk 
and Melzack, 1992). It is recommended that complaints 
of joint pain and muscle pain be carefully distinguished 
to ensure accurate reporting of symptoms. Complaints 
of  muscle  pain  should  be  described  as  sensations  of 
pain  or  aching  experienced  in  the  muscles  and  they 
should be distinguished from feelings of weakness or 
pain  experienced  in  other  areas  such  as  the  joints 
(Sharpe et al., 1991).  
  Headaches can occur in a variety of different forms 
and  are  typically  classified  into  the  following 
categories: vascular headaches (e.g., migraine, cluster, 
hypertensive),  muscle  contraction  headaches  (e.g., 
chronic  myositis,  cervical  osteoarthritis,  depressive 
equivalents and conversion reactions) and traction and 
inflammatory  headaches  (e.g.,  mass  lesions, 
temporomandibular joint, occlusive vascular disease). It 
is not sufficient to simply ask whether the patient has 
had  a  previous  or  lifelong  problem  with  headaches. 
Such  a  question  is  likely  to  result  in  inaccurate 
information  because  it  is  not  specific  enough. 
Assessment includes whether the headaches the patient Am. J. Biochem. & Biotech., 6 (2): 120-135, 2010 
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is  reporting  are  (1)  more  frequent  than  they  were 
before, which would indicate new pattern, (2) of a new 
type as compared to headaches previously experienced 
(i.e., location of pain has changed, nature of pain has 
changed) and (3) different in severity type as compared 
to headaches previously experienced by the patient. If a 
patient endorses these three criteria and indicates their 
headaches meet the frequency and severity cutoffs, then 
this  report  of  headaches  would  be  counted  toward 
fulfilling the pain criterion.  
 
Neurological/cognitive  manifestations:  The  fifth 
symptom  category  is  the  occurrence  of  two  or  more 
neurological/cognitive manifestations at frequency and 
severity  ratings  of  2  or  higher.  People  with  CFS 
typically  complain  that  fatigue  affects  their  physical 
and  mental  functioning.  Generally,  patients  report 
problems  with  concentration  and  absent  mindedness, 
impaired  memory,  difficulty  making  decisions, 
difficulties  taking  in  written  or  spoken  material  and 
executing familiar sequences of events, such as grocery 
shopping  (Wearden  and  Appleby,  1997).  In  addition, 
many  patients  with  CFS  complain  that  performing 
mental  work  is  aversive  for  them,  to  the  degree  that 
they  either  stop  doing  it  or  start  to  experience 
symptoms (Wood et al., 1994). Aside from cognitive 
manifestations,  many  people  experience  neurological 
symptoms  such  as  perceptual  disturbances  (e.g., 
inability  to  focus  vision  and  attention),  motor 
disturbances (e.g., muscle weakness and twitches) and 
overload  phenomenon  (e.g.,  sensitivity  to  light  or 
sound)  (Carruthers  et  al.,  2003).  As  a  result,  many 
people with CFS describe their neurological/cognitive 
difficulties as one of the more disabling and troubling 
symptoms of their illness.  
 
Autonomic,  neuroendocrine,  or  immune 
manifestations:  Finally,  the  sixth  symptom  category 
requires at least one symptom at frequency and severity 
ratings of 2 or higher from two of the following three 
subcategories:  (1)  Autonomic  manifestations,  (2) 
Neuroendocrine  manifestations  and  (3)  Immune 
manifestations.  
 
Autonomic manifestations: Autonomic manifestations 
include  neurally  mediated  hypotension,  postural 
orthostatic  tachycardia,  delayed  postural  hypotension, 
palpitations  with  or  without  cardiac  arrhythmias, 
dizziness,  feeling  unsteady  on  the  feet,  disturbed 
balance,  shortness  of  breath,  nausea,  bladder 
dysfunction and irritable bowel syndrome.  
 
Neuroendocrine  manifestations:  Neuroendocrine 
manifestations  include  recurrent  feelings  of 
feverishness  and  cold  extremities,  subnormal  body 
temperature and marked diurnal fluctuations, sweating 
episodes,  intolerance  of  extremes  of  heat  and  cold, 
marked  weight  change-loss  of  appetite  or  abnormal 
appetite and worsening of symptoms with stress.  
 
Immune  manifestations:  Immune  manifestations 
include recurrent flu-like symptoms, non-exudative sore 
or scratchy throat, repeated fevers and sweats, lymph 
nodes tender to palpitation--generally minimal swelling 
noted and new sensitivities to food, odors, or chemicals. 
Sore throat is one immune manifestation that is often 
difficult  to  assess  because  of  its  subjective  nature. 
While physical findings are sometimes present and can 
provide objective evidence of this symptom, often times 
such  findings  are  not  present.  According  to  a  study 
conducted  by  Gerber  et  al.  (1984),  sore  throat  is  the 
third most common reason for patient visits to primary 
care  practitioners.  Sore  throat  is  most  commonly 
associated  with  pharyngitis,  the  inflammation  of  the 
pharynx  and  surrounding  lymphoid  tissue.  There  are 
numerous  other  conditions,  however,  that  may  also 
produce sore throat. These conditions range from local 
disorders (e.g., ear, throat, nose infections) to systemic 
disorders  (e.g.,  CFS,  rheumatoid  arthritis,  viral 
hepatitis)  and  include  infectious  and  non-infectious 
etiologies (Muhrer, 1991).  
 
Medical and psychiatric evaluation: It is critical to do 
a medical evaluation in order to identify exclusionary 
medical diagnoses that would explain the fatigue and 
symptoms (Fukuda et al., 1994). Medical diagnoses that 
have  been  adequately  treated  (e.g.,  Lyme  disease)  or 
that  are  not  likely  to  cause  fatigue  should  not  be 
considered  exclusionary.  Table  1  lists  exclusionary 
medical  conditions  as  well  as  those  that  should  not 
necessarily be considered exclusionary and may present 
comorbidly with ME/CFS.  
  Psychiatric  evaluation  is  essential  to  rule  out 
psychiatric diagnoses that may be the cause of fatigue 
and preclude a diagnosis of CFS. The Structured Clinical 
Interview for the DSM-IV (SCID) (Spitzer et al., 1995), 
a semi-structured psychiatric interview, should be used 
for  psychiatric  evaluation.  Test-retest  reliability  was 
assessed  for  the  SCID  yielding  good  Kappa  scores 
(Williams et al., 1992). The professionally administered 
SCID allows for clinical judgment in the assignment of 
symptoms to psychiatric or medical categories, a crucial 
distinction  in  the  assessment  of  symptoms  that  overlap 
between  CFS  and  psychiatric  disorders,  e.g.,  fatigue, 
concentration  difficulty  and  sleep  disturbance.  A 
psychodiagnostic study (Taylor and Jason, 1998) validated 
the use of the SCID in a sample of CFS patients. Am. J. Biochem. & Biotech., 6 (2): 120-135, 2010 
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  Exclusionary  psychiatric  conditions  are  noted  in 
Table 1. Major Depressive Disorder with melancholic 
or  psychotic  features  are  considered  exclusionary 
conditions in our criteria, primarily due to the findings 
that  melancholic  and  psychotic  processes  represent 
distinct  biological  or  endocrinological  processes  and 
may  respond  well  to  antidepressant  or  antipsychotic 
medications  (Robbins  et  al.,  1989;  Schulkin,  1994). 
Reeves  et  al.  (2003)  has  recommended  that  Major 
Depressive  Disorder  with  melancholic  features, 
anorexia  nervosa,  or  bulimia,  not  be  considered 
exclusionary if these conditions have been resolved for 
more than 5 years before the onset of the current illness. 
However,  for  our  ME/CFS  case  definition,  eating 
disorders (i.e., anorexia nervosa and bulimia nervosa) 
and  substance  abuse  are  exclusionary  only  if  the 
diagnosis  is  current.  A  diagnosis  of  melancholic 
depression, substance abuse or eating disorder that has 
been appropriately treated and resolved should not be 
considered  exclusionary.  We  believe  that  psychotic 
disorders of any variety continue to be exclusionary.  
 
Predating criteria: The provision that the symptoms 
such as sore throat or memory impairment not predate 
the fatigue has also been  modified. Some individuals 
who develop ME/CFS experience a prodromal phase, in 
which symptoms begin to appear in the year prior to the 
onset  of  fatigue.  Jason  et  al.  (1999a)  compared  two 
groups  of  patients,  those  with  CFS  and  those  with 
chronic  fatigue  due  to  psychiatric  reasons.  Using  the 
two Fukuda et al. (1994) criteria of having six or more 
months of fatigue and the symptom not predating the 
illness,  only  one  of  eight  Fukuda  symptoms  were 
significantly  different  between  the  two  groups. 
However,  if  one  did  not  count  whether  a  symptom 
predated the illness and used both the 6 month criteria 
as  well  as  only  counting  moderate  to  serious 
manifestations of the illness  (as recommended in our 
current  case  definition),  then  four  out  of  the  eight 
symptoms were significantly differentiated between the 
two groups. There were significantly higher symptoms 
for the CFS group versus the psychiatric fatigued group 
for  muscle  pain  (46.9%  versus  24.2%),  headaches 
(50.0% versus 21.2%), impaired memory/concentration 
(65.6% versus 30.3%) and unrefreshing sleep (78.1% 
versus 39.4%). Therefore, it is not whether a symptom 
occurred before the illness, but the issue of severity of 
symptoms that is the best discriminator of those with 
CFS  versus  those  who  have  a  psychiatric  reason  for 
their fatigue. In our revised case definition, we count all 
symptoms even if they occurred prior to the onset of the 
fatigue.  
Meeting  research  versus  clinical  criteria:  Table  1 
provides all the symptoms as specified in the Revised 
Canadian  ME/CFS  case  definition.  Some  meet  full 
criteria whereas others who are very symptomatic do 
not  meet  full  criteria.  We  argue  as  we  did  with  the 
Pediatric case definition (Jason et al., 2006) that those 
that meet full criteria are more homogenous and might 
be best used for research purposes and we now classify 
these  individuals  as  meeting  the  Research  ME/CFS 
criteria. Still, others might have the illness but not meet 
one  of  the  required  criteria.  We  classified  such 
individual as meeting Clinical ME/CFS criteria. These 
individuals  needed  to  have  six  or  more  months  of 
fatigue and needed to report symptoms in five out of the 
six ME/CFS symptom categories (one of which has to be 
post  exertional  malaise,  as  it  is  critical  to  this  case 
definition).  In  addition,  for  autonomic,  neuroendocrine 
and immune manifestations, adults must have at least one 
symptom in any of these three categories, as opposed to 
one symptom from two of the three categories. We also 
have  a  category  called  Atypical  ME/CFS,  which  is 
defined as six or more months of fatigue, but having two 
to  four  ME/CFS  symptoms.  There  is  also  a  category 
called  ME/CFS-Like,  which  involves  exhibiting  all 
criteria  categories  but  for  a  duration  of  fewer  than  6 
months. Further, a person could be classified as having 
ME/CFS in remission if the person had previously been 
diagnosed with CFS by a physician but was not currently 
meeting  the  Research  ME/CFS  Criteria,  Clinical 
ME/CFS criteria, or Atypical ME/CFS criteria and must 
have 0 or 1 classic ME/CFS symptoms.  
 
CONCLUSION 
 
  In  this  study,  we  present  the  Revised  Canadian 
ME/CFS  case  definition,  which  provides  greater 
specification  to  the  work  of  Carruthers  et  al.  (2003). 
The scientific enterprise depends on reliable and valid 
ways of classifying patients into diagnostic categories 
and  this  critical  research  activity  can  enable 
investigators  to  better  understand  etiology, 
pathophysiology and treatment approaches for CFS and 
other  disorders  (King  and  Jason,  2005).  When 
diagnostic categories lack reliability and accuracy, the 
quality  of  treatment  and  clinical  research  can  be 
significantly compromised. A misdiagnosis may lead to 
improper treatment and in cases of severe illness, the 
matter  of  an  incorrect  diagnosis  can  have  serious 
consequences.  In  other  words,  the  validity  (i.e., 
usefulness)  of  a  diagnostic  category  is  inherently 
limited by its reliability. Therefore, to the extent to 
which a diagnostic category is unreliable, a limit is 
placed  on  its  validity  for  any  clinical  research Am. J. Biochem. & Biotech., 6 (2): 120-135, 2010 
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(Spitzer et al., 1975). The poor understanding of the 
pathophysiology  of  ME/CFS  may  be  due  case 
definitions  lacking  reliabiltiy  and  validity  and 
improving  the  case  definition  may  prevent 
complications in identifying biological markers in this 
illness.  Issues  concerning  reliability  of  clinical 
diagnosis  are  therefore  complex  and  have  important 
research and practical implications (Jason et al., 2005).  
  One  of  the  greatest  sources  of  diagnostic 
unreliability is criterion variance, which is differences 
in the formal inclusion and exclusion criteria used by 
clinicians to classify patients into diagnostic categories 
(Spitzer  et  al.,  1975).  Cantwell  (1996)  purports  that 
diagnostic  criteria  should  specify  which  diagnostic 
instrument to use, what informants to use and how to 
rate  for  presence  and  severity  of  the  criteria.  For 
example, one might specify that a certain number and 
type of symptoms should be present in order to make a 
particular  diagnosis.  In  addition  to  the  importance  of 
the  number  and  type  of  symptoms,  definitions  of 
fatigue  should  also  include  specific  guidelines 
pertaining to the importance of symptom severity in the 
diagnostic  procedure.  Given  the  high  variability  in 
symptom  severity  among  persons  with  fatigue, 
standardized  procedures  need  to  be  employed  for 
determining  whether  or  not  a  particular  symptom  is 
severe enough to qualify for the diagnosis of fatigue.  
  Although brief periods of fatigue (i.e., less than 1 
month duration) occur in approximately 15-25% of the 
population, chronic fatigue occurs in about 4-5% of the 
population (Jason et al., 2010b). In a community-based 
epidemiologic study of fatigue (Jason et al., 1999b), of 
those  identified  with  six  or  more  months  of  fatigue, 
54%  had  chronic  fatigue  explained  by  medical  or 
psychiatric reasons, including cancer, multiple sclerosis 
and  melancholic  depression.  If  about  5%  of  the 
population has six or more months of fatigue and about 
half  of  this  is  due  to  clear  medical  or  psychiatric 
reasons, then the critical question is how many of the 
remaining 2.5% have ME/CFS? The empiric CFS case 
definition (Reeves et al., 2005) estimates that 2.54% do 
have this illness, so that research group would suggest 
that  almost  all  would  fall  within  the  CFS  category. 
However, Jason et al. (2009b) believe that within this 
2.54% are mood disorders, which are one of the most 
prevalent psychiatric disorders (1 month prevalence rate 
of  major  depressive  episode  is  2.2%)  (Regier  et  al., 
1988).  As  an  example,  Major  Depressive  Disorder 
(MDD) can be confused with ME/CFS because it has 
some  overlapping  symptoms  with  the  illness.  It  is 
possible  that  some  patients  with  MDD  also  have 
chronic fatigue and four Fukuda et al. (1994) symptoms 
that can occur with depression (e.g., unrefreshing sleep, 
joint pain, muscle pain, impairment in concentration). 
Consequently, it is possible that some patients with a 
primary  mood  disorder  could  be  misdiagnosed  as 
having  ME/CFS.  Yet,  these  are  distinct  illnesses,  as 
several ME/CFS symptoms are not commonly found in 
depression, including prolonged fatigue after physical 
exertion, night sweats, sore throats and swollen lymph 
nodes. Illness onset with ME/CFS often occurs over a 
few hours or days, whereas primary depression generally 
shows  a  more  gradual  onset.  Biological  findings  also 
differentiate the two conditions (Jason et al., 2005). The 
inclusion  of  the  latter  type  of  patients  in  the  current 
ME/CFS  case  definition  could  confound  the 
interpretation  of  epidemiologic  and  treatment  studies; 
therefore,  complicating  efforts  to  identify  biological 
markers for this illness.  
  The  DePaul  Symptom  Questionnaire  is  a  useful 
screening tool to assess for ME/CFS according to the 
Revised Canadian ME/CFS case definition, but it does 
not  provide  the  full  picture  of  a  patient’s 
symptomatology.  Thus,  for  research  purposes,  we 
propose  some  additional  measures  that  could  be 
administered  to  obtain  more  comprehensive  data  on 
symptomatology.  For  fatigue,  the  Fatigue  Severity 
Scale (FSS) (Krupp et al., 1989) is a measure of the 
behavioral      consequences  of  fatigue.  In  a  study  by 
Jason et al. (2010e), the FSS was found to have a better 
ability  to  detect  cases  and  non-cases  than  the  MFI 
(Smets et al., 1995), the Fatigue Scale (Chalder et al., 
1993)  and  the  Profile  of  Fatigue-Related  Symptoms 
(Ray et al., 1992). For sleep disturbances, we suggest 
the Pittsburgh Sleep Quality Index (Buysse, 1989) for 
measuring sleep disruptions and sleep quality. Finally, 
pain symptoms can be assessed with the McGill Pain 
Questionnaire,  a  well-validated  measure  (Melzack, 
1975). 
  Fukuda  et  al.  (1994)  recommended  subgrouping 
adult  CFS  patients  and  while  not  the  focus  of  this 
article, similar efforts suggest this would be appropriate 
in the study of ME/CFS (Jason et al., 2005). Cancer and 
heart disease are comprised of many subtypes and this 
may also be the case with ME/CFS. Although ME/CFS 
has also been referred to as unexplained fatigue, this is 
also changing with scientific discoveries. For research 
purposes, each of the six domains that are assessed with 
the Revised Canadian criteria may be operationalized in 
more objective and precise ways in the future. For the 
fatigue criterion, efforts are ongoing to measure actual 
behavioral abnormalities among ME/CFS patients using 
actigraphs (Tryon et al., 2004). Post-exertional fatigue 
and  pain  can  be  measured  by  increases  in  the 
expression for sensory, adrenergic and immune genes 
following  moderate  exercise  (Light  et  al.,  2009). Am. J. Biochem. & Biotech., 6 (2): 120-135, 2010 
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Unrefreshing sleep or disturbance of sleep quantity or 
rhythm  disturbance  will  be  measured  by 
polysomnography  (Shaver,  2003). 
Neurological/cognitive  manifestations  could  be 
measured  by  objective  evidence  using  functional 
Magnetic  Resonance  Imaging  (fMRI)  (Lange  et  al., 
2005).  Autonomic manifestations could be assessed 
by  ejection  fraction  decreases,  suggesting  left 
ventricular dysfunction in the heart (Peckerman et al., 
2003).  Neuroendocrine  manifestations  can  be 
measured  by  abnormal  levels  of  circulating  cortisol 
(Torres-Harding  et  al.,  2008).  Finally,  immune 
manifestations  could  be  measured  by  elevations  in 
CD5+CD19+  subset  and  decreased  natural  killer  cell 
cytotoxicity (Maher et al., 2003). 
  In  conclusion,  studies  examining  sources  of 
diagnostic  unreliability  have  shown  that  criterion 
variance,  differences  in  the  formal  inclusion  and 
exclusion criteria used by clinicians to classify patients’ 
data into diagnostic categories, accounts for the largest 
source of diagnostic unreliability (Spitzer et al., 1975). 
Moreover,  research  has  demonstrated  that  criterion 
variance  is  most  likely  to  occur  when  operationally 
explicit  criteria  do  not  exist  for  diagnostic  categories 
(Spitzer  et  al.,  1978).  The  provision  of  either  a 
structured  or  semi-structured  standardized  instrument 
designed  to  elicit  the  required  information  (formal 
inclusion and exclusion criteria) would greatly reduce 
this  source  of  variance  and  improve  the  diagnostic 
reliability  of  CFS.  If  ME/CFS  is  to  be  diagnosed 
reliably across health care professionals, we believe that 
it  is  imperative  to  provide  specific  thresholds  and 
scoring  rules  for  the  symptom  criteria.  Without  such 
standardization, symptom variability will be a function 
of the assessment procedure and etiological factors. In 
other  words,  by  determining  specific  thresholds  and 
scoring  rules  for  the  symptom  criteria,  variability  is 
likely to result in increased diagnostic reliability.  
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